DocMorris AG
SIX:DOCM
DocMorris AG
Stock-Based Compensation
DocMorris AG
Stock-Based Compensation Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Stock-Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
DocMorris AG
SIX:DOCM
|
Stock-Based Compensation
CHf3.4m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
DocMorris AG
Glance View
DocMorris Ltd. engages in the operation of an e-commerce pharmacy and the wholesale of medical and pharmaceutical products. The company is headquartered in Frauenfeld, Thurgau and currently employs 2,283 full-time employees. The company went IPO on 2017-07-06. The firm focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The firm's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The firm operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.
See Also
What is DocMorris AG's Stock-Based Compensation?
Stock-Based Compensation
3.4m
CHF
Based on the financial report for Jun 30, 2025, DocMorris AG's Stock-Based Compensation amounts to 3.4m CHF.
What is DocMorris AG's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 5Y
-22%
Over the last year, the Stock-Based Compensation growth was 67%. The average annual Stock-Based Compensation growth rates for DocMorris AG have been -31% over the past three years , -22% over the past five years .
